We are thrilled to announce that following the launch of our equity crowdfunding campaign on StartEngine on May 20th, we have already exceeded $500,000 in investments. As we write this, Epi One ranks among the top 15 campaigns on the platform in terms of funds raised over the past 72 hours.
“To have raised this amount in just two weeks is beyond our expectations”, says Epi One CEO Michael Marquardt. “The StartEngine campaign provides individuals with a unique opportunity to own a part of a company dedicated to revolutionizing cancer diagnostics and, ultimately, saving millions of lives. The initial response has been phenomenal and perhaps illustrates the collective desire of the world to tackle this disease.”
Our mission is to make a profound impact in the health technology sector, and every investment brings us closer to that goal. The funds from our equity crowdfunding campaign complement the $3.1 million previously raised in angel funding, propelling us forward in our journey and enabling us to complete clinical validation of our testing platform for additional cancer types and to further expand our laboratory space.
The equity crowdfunding campaign is now live on StartEngine, offering investors the chance to be a part of Epi One’s growth and innovation. You can find details of the offering at StartEngine’s Epi One offering page.
